MedPath

Jikei SiTagliptin vs Alpha-glucosidase inhibitor treatment Research by CGM

Not Applicable
Conditions
type 2 diabetes
Registration Number
JPRN-UMIN000004916
Lead Sponsor
Jikei University School of Medicine 3-25-8 Nishishimbashi, Minato-ku, Tokyo 105-8461 Japan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

type 1 diabetes diabetic ketosis infection past history of abdominal operation past history of ileus renal failure liver damage on insulin treatment past history of allergy against Sitagliptin or Voglibose

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
glucose variability
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath